Daniel Labar

2.1k total citations
52 papers, 1.7k citations indexed

About

Daniel Labar is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology. According to data from OpenAlex, Daniel Labar has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Daniel Labar's work include Medical Imaging Techniques and Applications (24 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Advanced MRI Techniques and Applications (12 papers). Daniel Labar is often cited by papers focused on Medical Imaging Techniques and Applications (24 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Advanced MRI Techniques and Applications (12 papers). Daniel Labar collaborates with scholars based in Belgium, United States and France. Daniel Labar's co-authors include Anne Bol, Vincent Grégoire, Christian Michel, Thierry Vander Borght, Anne De Volder, John A. Lee, Bernard Gallez, Ann Coppens, M. Sibomana and Stanislas Pauwels and has published in prestigious journals such as Circulation, Gastroenterology and Chemical Communications.

In The Last Decade

Daniel Labar

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Labar Belgium 22 911 352 280 205 184 52 1.7k
K. Hamacher Germany 16 1.2k 1.4× 308 0.9× 279 1.0× 336 1.6× 106 0.6× 33 2.1k
Michail Plotkin Germany 29 979 1.1× 128 0.4× 571 2.0× 145 0.7× 145 0.8× 77 2.4k
P. Som United States 20 1.4k 1.6× 322 0.9× 401 1.4× 360 1.8× 125 0.7× 64 2.5k
Tatsuo Torizuka Japan 30 1.2k 1.3× 414 1.2× 644 2.3× 320 1.6× 78 0.4× 65 3.2k
H.-J. Machulla Germany 19 1.7k 1.9× 600 1.7× 594 2.1× 336 1.6× 123 0.7× 56 2.5k
D. Pauleit Germany 24 1.5k 1.7× 303 0.9× 463 1.7× 296 1.4× 78 0.4× 58 2.8k
Josef Vymazal Czechia 25 775 0.9× 117 0.3× 345 1.2× 327 1.6× 497 2.7× 66 2.5k
Stephen Adler United States 23 659 0.7× 137 0.4× 510 1.8× 253 1.2× 136 0.7× 59 1.7k
Safiye Osman United Kingdom 24 1.3k 1.4× 298 0.8× 292 1.0× 541 2.6× 99 0.5× 38 2.3k
H.‐J. Machulla Germany 18 1.1k 1.2× 309 0.9× 231 0.8× 197 1.0× 257 1.4× 43 1.7k

Countries citing papers authored by Daniel Labar

Since Specialization
Citations

This map shows the geographic impact of Daniel Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Labar more than expected).

Fields of papers citing papers by Daniel Labar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Labar. The network helps show where Daniel Labar may publish in the future.

Co-authorship network of co-authors of Daniel Labar

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Labar. A scholar is included among the top collaborators of Daniel Labar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Labar. Daniel Labar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ivashkin, Pavel, et al.. (2014). [18F]CuCF3: A [18F]Trifluoromethylating Agent for Arylboronic Acids and Aryl Iodides. Chemistry - A European Journal. 20(31). 9514–9518. 64 indexed citations
2.
Bol, Anne, Daniel Labar, Oussama Karroum, et al.. (2014). Potential role of hypoxia imaging using 18F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy. Radiotherapy and Oncology. 113(2). 204–209. 25 indexed citations
3.
Bol, Vanesa, Anne Bol, Caroline Bouzin, et al.. (2014). Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation. Acta Oncologica. 54(2). 266–274. 32 indexed citations
4.
Bol, Anne, Daniel Labar, Bénédicte F. Jordan, et al.. (2012). Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: A comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry. Radiotherapy and Oncology. 105(1). 29–35. 61 indexed citations
5.
Christian, Nicolas, Anne Bol, Marc De Bast, et al.. (2010). Is 18F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer 14C-EF3 in animal tumor models. Radiotherapy and Oncology. 97(2). 183–188. 30 indexed citations
6.
Rommel, Denis, Anne Bol, Jorge Abarca‐Quinones, et al.. (2009). Rodent Rhabdomyosarcoma: Comparison Between Total Choline Concentration at H-MRS and [18F]-fluoromethylcholine Uptake at PET Using Accurate Methods for Collecting Data. Molecular Imaging and Biology. 12(4). 415–423. 6 indexed citations
7.
Mahy, Pierre, Marc De Bast, Tjibbe de Groot, et al.. (2008). Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models. Radiotherapy and Oncology. 89(3). 353–360. 18 indexed citations
8.
Christian, Nicolas, Anne Bol, Marc De Bast, et al.. (2007). Determination of tumour hypoxia with the PET tracer [18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model. European Journal of Nuclear Medicine and Molecular Imaging. 34(9). 1348–1354. 16 indexed citations
9.
Labar, Daniel, et al.. (2004). Perfluorinated markers for hypoxia detection: synthesis of sulfur-containing precursors and [18F]-labelling. Bioorganic & Medicinal Chemistry. 13(4). 1357–1367. 9 indexed citations
10.
Jamar, François, Raffaella Barone, Isabelle Mathieu, et al.. (2003). 86Y-DOTA0-d-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion. European Journal of Nuclear Medicine and Molecular Imaging. 30(4). 510–518. 177 indexed citations
11.
Walrand, Stéphan, François Jamar, Isabelle Mathieu, et al.. (2002). Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86. European Journal of Nuclear Medicine and Molecular Imaging. 30(3). 354–361. 75 indexed citations
12.
Levêque, Philippe, Daniel Labar, & Bernard Gallez. (2001). Biodistribution, binding specificity and metabolism of [ 18 F]fluoroethylflumazenil in rodents. Nuclear Medicine and Biology. 28(7). 809–814. 12 indexed citations
13.
Levêque, Philippe, Edmond de Hoffmann, Daniel Labar, & Bernard Gallez. (2001). Assessment of [18F]fluoroethylflumazenil metabolites using high-performance liquid chromatography and tandem mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 754(1). 35–44. 8 indexed citations
14.
Bohórquez, Sandra Sanabria, Daniel Labar, Philippe Levêque, et al.. (2000). [11C]Flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification. European Journal of Nuclear Medicine and Molecular Imaging. 27(11). 1674–1683. 16 indexed citations
15.
Bentourkia, M’hamed, Christian Michel, G. Ferrière, et al.. (1998). Evolution of brain glucose metabolism with age in epileptic infants, children and adolescents. Brain and Development. 20(7). 524–529. 23 indexed citations
16.
Jamar, François, Augustin Ferrant, N. Leners, & Daniel Labar. (1992). [2-c-11]-thymidine Pet Scan in Non-hodgkin Lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 19(8). 693–693. 1 indexed citations
17.
Borght, Thierry Vander, et al.. (1992). Comparison of Thymidine Labeled in Methyl-group and in 2c-ring Position in Human Pet Studies. European Journal of Nuclear Medicine and Molecular Imaging. 19(8). 578–578. 3 indexed citations
18.
Borght, Thierry Vander, Stanislas Pauwels, Luc Lambotte, et al.. (1991). PET study of human cerebral malignancy with [2-11C]thymidine and [18F]FDG.. European Journal of Nuclear Medicine and Molecular Imaging. 18. 540. 2 indexed citations
19.
Borght, Thierry Vander, Stanislas Pauwels, Luc Lambotte, Daniel Labar, & Christian Beckers. (1990). In vivo evaluation of liver regeneration using PET and [2-11C] thymidine.. European Journal of Nuclear Medicine and Molecular Imaging. 16. 421.
20.
Goffinet, André M., Josée E. Leysen, & Daniel Labar. (1990). In vitro Pharmacological Profile of 3-N-(2-Fluoroethyl)Spiperone. Journal of Cerebral Blood Flow & Metabolism. 10(1). 140–142. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Hamacher Breakdown of academic impact, for papers by Michail Plotkin Breakdown of academic impact, for papers by P. Som Breakdown of academic impact, for papers by Tatsuo Torizuka Breakdown of academic impact, for papers by H.-J. Machulla Breakdown of academic impact, for papers by D. Pauleit Breakdown of academic impact, for papers by Josef Vymazal Breakdown of academic impact, for papers by Stephen Adler Breakdown of academic impact, for papers by Safiye Osman Breakdown of academic impact, for papers by H.‐J. Machulla
Rankless by CCL
2026